Novel Assay Using Total Hepatitis C Virus (HCV) Core Antigen quantification for Diagnosis of HCV Infection in Dialysis Patients

Dialysis patients remain a high-risk group for hepatitis C virus (HCV) infection. The current diagnosis of HCV infection among dialysis patients includes serological assays and nucleic acid amplification technology (NAT) for assessing serum anti-HCV antibody and HCV viremia, respectively. However, c...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Microbiol
Autors principals:	Fabrizi, Fabrizio, Lunghi, Giovanna, Aucella, Filippo, Mangano, Stefano, Barbisoni, Francesco, Bisegna, Sergio, Vigilante, Domenico, Limido, Aurelio, Martin, Paul
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2005
Matèries:	Virology
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC540167/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15635003/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.43.1.414-420.2005
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!